BRADYKININ AND BLOOD PRESSURE RESPONSE TO RAMIPRIL

雷米普利的缓激肽和血压反应

• 批准号: 7375592
• 负责人: Nancy J. Brown
• 金额: $ 1.34万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375592
• 关键词: BRADYKININ; BLOOD; PRESSURE; RESPONSE; RAMIPRIL

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to find out how ACE inhibitors lower PAI-1. We believe that ACE inhibitors may lower PAI-1 by increasing a chemical in the body called nitric oxide. For this reason, we will measure the effect of an ACE inhibitor, ramipril; a dietary supplement that increases nitric oxide, L-arginine; and an intravenous drug that decreases nitric oxide, L-NAME, on clotting factors in the blood.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本研究的目的是了解ACE抑制剂如何降低派-1。我们认为ACE抑制剂可能通过增加体内一种叫做一氧化氮的化学物质来降低派-1。出于这个原因，我们将测量ACE抑制剂雷米普利、增加一氧化氮的膳食补充剂L-精氨酸和减少一氧化氮的静脉注射药物L-NAME对血液中凝血因子的影响。